The JHH cohort identified 1,454 patients who underwent a native kidney biopsy between January 2019 and December 2022, while the Yale cohort examined 528 patients who were scheduled to undergo a ...

“Patients are different, especially lupus patients, and so one lupus nephritis patient may have different clinical characteristics, different thoughts about what therapy will work for them in ...

Pathological material, which was obtained for study in two of the patients who received penicillin and in two who were given methicillin, showed a characteristic type of interstitial nephritis ...

Despite following the same basic recommendations as the adult guidelines, the pediatric LN guidelines included special ...

ACR 2024 highlighted new guidelines for the screening, treatment, and management of lupus nephritis, stressing prompt kidney biopsy and timely treatment.

The ACR has released a summary of a new 2024 guideline for the screening, treatment, and management of Lupus Nephritis.

GLP-1 RAs might lower kidney failure risk in patients with lupus nephritis by reducing pro-inflammatory mediators. Glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment in patients with ...

Henlius Biotech CEO and executive director Dr Jason Zhu stated: “We are pleased to expand our collaboration with Palleon ...

The following is a summary of “Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a ...

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.